Prathamesh Kale

Prathamesh Kale

Auto-generated profile, based on publicly available information

Prathamesh Kale

Serum Institute of India Pvt Ltd., 212/2, Hadapsar, Pune, Maharashtra 411028, India

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 December 2017 in Journal of Ayurveda and Integrative Medicine
Verified
Journal Article
Open access
SSSushant A. Shengule
Sushant A. Shengule
SMSanjay Mishra
Sanjay Mishra
KJKalpana Joshi
Kalpana Joshi
KAKishori Apte
Kishori Apte
DPDada Patil
Dada Patil
APAmrutesh Puranik
Amrutesh Puranik
Background: Arjunarishta (AA), a formulation used as cardiotonic is a hydroalcoholic formulation of Terminalia arjuna (Roxb.) Wight and Arn. (TA) belonging to family Combretaceae. Objective: To evaluate the anti-hyperglycemic and anti-hyperlipidemic effect of Arjunarishta on high-fat diet fed animals. Materials and methods High-fat diet fed (HFD) Wistar rats were randomly divided into three groups and treated with phytochemically standardized Arjunarishta (1.8 ml/kg), and hydroalcoholic extract of T. arjuna (TAHA) (250 mg/kg) and rosuvastatin (10 mg/kg), for 3 months. Intraperitoneal glucose tolerance test, blood biochemistry, liver triglyceride and systolic blood pressure were performed in all the groups. Effect of these drugs on the expression of tumor necrosis factor-α (TNF-α) and insulin receptor substrate-1 (IRS-1) and peroxisome proliferators activated receptor γ coactivator 1-α (PGC-1α) were studied in liver tissue using Quantitative Real-time PCR. Results: HFD increased fasting blood glucose, liver triglyceride, systolic blood pressure and gene expression of TNF-α, IRS-1 and PGC-1α. Treatment of AA and TAHA significantly reduced fasting blood glucose, systolic blood pressure, total cholesterol and triglyceride levels. These treatments significantly decreased gene expression of TNF-α (2.4, 2.2 and 2.6 fold change); increased IRS-1 (2.8, 2.9 and 2.8 fold change) and PGC-1α (2.9, 3.7 and 3.3 fold change) as compared to untreated HFD. Conclusion: Anti-hyperglycemic, anti-hyperlipidemic effect of Arjunarishta may be mediated by decreased TNF-α and increased PGC-1α and IRS-1.

1 April 2019 in Methods
Verified
Journal Article
Closed access
LKLaxmikant Kadam
Laxmikant Kadam
KPKrunal Patel
Krunal Patel
MGManish Gautam
Manish Gautam
STShrikant Thorat
Shrikant Thorat
PKPrathamesh Kale
Prathamesh Kale
SGSunil Gairola
Sunil Gairola